Ventilator-associated pneumonia (VAP) poses a serious threat in ICUs, often driven by biofilms on endotracheal tubes that resist antibiotics. In this Q&A, Professor Frank MP van Haren discusses a study showing that nebulized BromAc® effectively disrupts these biofilms and enhances antibiotic action, offering a promising strategy against persistent infections like Pseudomonas aeruginosa-related VAP.

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

In this Future Leaders interview, we speak with Dr Kaylee Worlock, post-doctoral research fellow at UCL and winner of the 2025 Rising Stars award at the 7th Forum on RTIs. Dr Worlock shares her journey into respiratory science, her pioneering work in developmental biology, and her vision for the future of translational research.

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Dr. Véronique Suttels discusses her work on improving tuberculosis (TB) diagnostics in low-resource settings through AI-assisted lung ultrasound (LUS). In this Future Leaders interview, Dr Suttels outlines the potential challenges of implementing diagnostic tools like CAD LUS4TB across multiple countries and reflects on the role of technology in addressing diagnostic gaps. Her research highlights both the potential and limitations of AI in advancing equitable, scalable solutions for global TB control.

Back in February 2025, the 7th Forum on Respiratory Tract Infections (RTI) took place at the iconic Glasgow Science Centre - a fitting venue for a scientific conference built on innovation, collaboration and ground-breaking research. Each year RTI continues to grow ...

As part of our Future Leaders series, we spoke with Dr Amy Wolfe, Director of the LSUHSC-Wetmore TB Clinic and Assistant Professor of Medicine at LSUHSC in New Orleans. A specialist in pulmonary and critical care medicine, Dr Wolfe shares how her early experiences in post-Katrina New Orleans inspired her focus on health equity. She discusses the challenges of treating TB in underserved communities, the importance of wraparound care, and promising innovations in pulmonology—from AI-based diagnostics to expanded access to pulmonary rehabilitation and lung cancer screening.

As part of our Future Leaders series, we speak with Dr Helen Gavillet, a post-doctoral researcher at Northumbria University (UK) and Rising Star at RTI 2025. Dr Gavillet's research focuses on the lung microbiome in cystic fibrosis, particularly bacterial and fungal dynamics. Her research also examines the impact of CFTR modulators like elexacaftor/tezacaftor/ivacaftor on respiratory microbiota.